DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-429 Cr | ₹-974 Cr | ₹-629 Cr | ₹-1,276 Cr | ₹-1,040 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of DR REDDYS LABORATORIES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹-429 Cr |
Mar2024 | ₹-974 Cr |
Mar2023 | ₹-629 Cr |
Mar2022 | ₹-1,276 Cr |
Mar2021 | ₹-1,040 Cr |
How is Deferred Tax Assets / Liabilities of DR REDDYS LABORATORIES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹-429 Cr | Negative | |
Mar2024 | ₹-974 Cr | Negative | |
Mar2023 | ₹-629 Cr | Negative | |
Mar2022 | ₹-1,276 Cr | Negative | |
Mar2021 | ₹-1,040 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of DR REDDYS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR REDDYS LABORATORIES | ₹109,378.5 Cr | 0.5% | 4.1% | -2.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹386,497.0 Cr | 1.1% | -1.9% | -14.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,787.0 Cr | 1.1% | -0.6% | 10.4% | Stock Analytics | |
CIPLA | ₹125,870.0 Cr | -0.4% | -0.4% | -6.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,591.0 Cr | -1.7% | -2.5% | 2.1% | Stock Analytics | |
MANKIND PHARMA | ₹106,044.0 Cr | -1.5% | 3.9% | 6.2% | Stock Analytics |
DR REDDYS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR REDDYS LABORATORIES | 0.5% |
4.1% |
-2.7% |
SENSEX | 1.6% |
2.3% |
1.1% |
You may also like the below Video Courses